Aclaris Therapeutics (ACRS) Cash & Current Investments (2014 - 2026)
Aclaris Therapeutics (ACRS) posted Cash & Current Investments of $91.56 million for Q2 2026, down 8.3% from $99.81 million a year earlier and down 13.1% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Cash & Current Investments (2014 - 2026) Analysis & Trends
At the end of FY2025, Aclaris Therapeutics' Cash & Current Investments came in at $90.75 million, down 20.1% from FY2024.
- Annual Cash & Current Investments has declined for three consecutive years, though with a five-year compound annual growth rate of 10.9% (FY2020 to FY2025).
- In prior years, Aclaris Therapeutics' Cash & Current Investments was $113.59 million in FY2024 (-4.6%), $119.11 million in FY2023 (-45.3%), $217.57 million in FY2022 (+13.7%) and $191.41 million in FY2021 (+253.6%).
- Quarterly Cash & Current Investments has run from a low of $90.75 million in Q4 2025 to a high of $248.6 million in Q2 2022 over five years.
- On a year-over-year basis, Cash & Current Investments increased in two of the last eight quarters, with an average decline of 7.7%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2021, with growth of 258.3%; the weakest was Q3 2023, with a decline of 58.5%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $105.42 million (Q1 2026), $90.75 million (Q4 2025) and $95.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Aclaris Therapeutics | 524.34 Mn | 140.71 Mn | 1.41 Mn | 91.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91.56 Mn |
| Mar 31, 2026 | 105.42 Mn |
| Dec 31, 2025 | 90.75 Mn |
| Sep 30, 2025 | 95.91 Mn |
| Jun 30, 2025 | 99.81 Mn |
| Mar 31, 2025 | 105.31 Mn |
| Dec 31, 2024 | 113.59 Mn |
| Sep 30, 2024 | 127.72 Mn |
| Jun 30, 2024 | 111.09 Mn |
| Mar 31, 2024 | 128.17 Mn |
| Dec 31, 2023 | 119.11 Mn |
| Sep 30, 2023 | 103.05 Mn |
| Jun 30, 2023 | 119.78 Mn |
| Mar 31, 2023 | 170.80 Mn |
| Dec 31, 2022 | 217.57 Mn |
| Sep 30, 2022 | 248.06 Mn |
| Jun 30, 2022 | 248.60 Mn |
| Mar 31, 2022 | 179.62 Mn |
| Dec 31, 2021 | 191.41 Mn |
| Sep 30, 2021 | 197.88 Mn |
API Access
Aclaris Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();